Publications (28) Publications in which a researcher has participated

filter_list Ophthalmology

2024

  1. An Observational Study in the Real Clinical Practice of the Treatment of Noninfectious Uveitis

    Journal of Clinical Medicine, Vol. 13, Núm. 5

  2. Interobserver Reliability and Sensitivity to Change of a Composite Ocular Inflammatory Activity Index: UVEDAI©

    Ophthalmology and Therapy, Vol. 13, Núm. 6, pp. 1669-1682

2023

  1. AB1470 Janus Kinase Inhibitors in Severe Inflammatory Ocular Pathology. Multicenter Study and Literature Review

    Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 1963.2-1964

  2. Correction to: Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis (Ophthalmology and Therapy, (2023), 12, 2, (1045-1055), 10.1007/s40123-023-00654-8)

    Ophthalmology and Therapy

  3. POS0652 Interobserver Reliability and Sensitivity to Change of a Composite Ocular Inflammatory Activity Index: Uvedai

    Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 604-605

  4. POS0793-HPR Observational Study in Real Clinical Practice of the Treatment of Non-Infectious Uveitis (PÓSTER)

    Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 689.2-690

  5. Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis

    Ophthalmology and Therapy, Vol. 12, Núm. 2, pp. 1045-1055

2022

  1. Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients

    Clinical and Experimental Rheumatology

2021

  1. AB0396 Rapid Improvement in Cystoid Macular Edema With High Dose Intravenous Methylprednisolone in Non-Infectious Uveitis ff Different Immune Mediated Inflammatory Diseases

    Annals of the Rheumatic Diseases, Vol. 80, Núm. Suppl 1, pp. 1225.3-1226

  2. Epidemiology of Uveitis in a Spanish Region: Prevalence and Etiology

    Ophthalmic Epidemiology, Vol. 28, Núm. 3, pp. 227-236

  3. Measuring Choroid Thickness as a Marker of Systemic Inflammation in Patients with Ankylosing Spondylitis

    Journal of Clinical Rheumatology, Vol. 27, Núm. 8, pp. E307-E311

2020

  1. AB0726 Choroidal Thickness Is a Biomarker a and Can Predict The Response to Treatment in Ankylosing Spondylitis

    Annals of the Rheumatic Diseases, Vol. 79, Núm. Suppl 1, pp. 1657.1-1658

  2. Choroidal Thickness Is a Biomarker Associated With Response to Treatment in Ankylosing Spondylitis

    JCR: Journal of Clinical Rheumatology

  3. Reproducibilidad de la medición manual del grosor coroideo utilizando la tomografía de coherencia óptica

    Archivos de la Sociedad Española de Oftalmologia, Vol. 95, Núm. 8, pp. 379-385

2019

  1. Choroidal and retinal thickness in systemic autoimmune and inflammatory diseases: A review

    Survey of Ophthalmology, Vol. 64, Núm. 6, pp. 757-769

  2. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

    Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089

  3. Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behçet’s disease associated uveitis: a systematic review

    Rheumatology International, Vol. 39, Núm. 1, pp. 47-58

  4. Visual acuity loss and development of ocular complications in white dot syndromes: a longitudinal analysis of 3 centers

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 257, Núm. 11, pp. 2505-2516

2018

  1. SAT0622 High dose intravenous methylprednisolone induces rapid improvement in severe uveitis: a multicenter study of 129 patients

    Annals of the Rheumatic Diseases, Vol. 77, pp. 1162-1163

  2. Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease

    Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451